Celldex

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.

CEO

Anthony S. Marucci

CEOAnthony S. Marucci

Employees

186

Employees186

Headquarters

Hampton, New Jersey

HeadquartersHampton, New Jersey

Founded

1983

Founded1983

Employees

186

Employees186

CLDX Key Statistics

Market cap

1.80B

Market cap1.80B

Price-Earnings ratio

-9.00

Price-Earnings ratio-9.00

Dividend yield

—

Dividend yield—

Average volume

704.78K

Average volume704.78K

High today

$27.65

High today$27.65

Low today

$26.80

Low today$26.80

Open price

$27.24

Open price$27.24

Volume

507.05K

Volume507.05K

52 Week high

$29.05

52 Week high$29.05

52 Week low

$14.40

52 Week low$14.40

CLDX News

Simply Wall St 5d

Celldex Therapeutics: Evaluating Valuation After Barclays’ Cautious Coverage and Renewed Safety Concerns

Barclays has just initiated coverage of Celldex Therapeutics (CLDX), taking a cautious view on the stock because of ongoing safety concerns and a competitive la...

Analyst ratings

81%

of 16 ratings

Buy

81.3%

Hold

12.5%

Sell

6.3%

People also own

Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.